Brief: Orexo Expects FDA Filing Of OX124 Mid 2022

Orexo AB

29/01/2021 15:54

Jan 29 (Reuters) - Orexo AB  ORX.ST :
    * OREXO EXPECTS FDA FILING OF OX124 MID 2022
    * IF APPROVED, OX124 IS ESTIMATED TO HAVE A SALES POTENTIAL
OF USD
70 - 110 MILLION

Source text for Eikon:  ID:nWkrb3DyVp 
Further company coverage:  ORX.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))